Escherichia/Shigella, SCFAs, and Metabolic Pathways—The Triad That Orchestrates Intestinal Dysbiosis in Patients with Decompensated Alcoholic Cirrhosis from Western Mexico
Tonatiuh Abimael Baltazar-Díaz(Universidad de Guadalajara), Miriam Ruth Bueno‐Topete(Universidad de Guadalajara), Adelaida Sara Minia Zepeda‐Morales(Universidad de Guadalajara), Marcela Peña‐Rodríguez(Universidad de Guadalajara), Rocío Ivette López-Roa(Universidad de Guadalajara), Adriana María Salazar-Montes(Universidad de Guadalajara), Erika Martínez‐López(Universidad de Guadalajara), Susana del Toro‐Arreola(Universidad de Guadalajara), Natali Vega‐Magaña(Universidad de Guadalajara), J.M. Aldana-Ledesma(Hospital Civil de Guadalajara), Luz Alicia González-Hernández(Universidad de Guadalajara)
Cited by 96
Related Papers
Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial
|The Lancet Respiratory Medicine|2021|225
Quercetin, a Flavonoid with Great Pharmacological Capacity
|Molecules|2024|204
Follicular CD8 T cells accumulate in HIV infection and can kill infected cells in vitro via bispecific antibodies
|Science Translational Medicine|2017|169
Oral Manifestations Associated with HIV/AIDS Patients
|Medicina|2022|97